Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shot up 24.2% during trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.21. 280,394 shares traded hands during trading, a decline of 48% from the average session volume of 537,707 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Price Performance
The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The business has a 50-day moving average price of C$0.10 and a two-hundred day moving average price of C$0.07. The firm has a market capitalization of C$27.89 million, a price-to-earnings ratio of -20.00 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- Stock Splits, Do They Really Impact Investors?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is the S&P 500 and How It is Distinct from Other Indexes
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
